Abstract
Inflammasomes are intracellular protein complexes of pattern recognition receptors and caspase-1, with essential functions in regulating inflammatory responses of macrophages and dendritic cells. The primary role of inflammasomes is to catalyze processing and secretion of pro-inflammatory cytokines IL-1β and IL-18. Recently, intracellular non-canonical inflammasome activation by caspases-4/5, which are also regulators of pyroptosis via processing gasdermin D, has been elucidated. Caspase-1, the effector protease of inflammasome complex, is also known to modulate secretion of large number of other proteins. Thereby, besides its known role in processing pro-inflammatory cytokines, the inflammasome turns into a universal regulator of protein secretion, which allows the danger-exposed cells to release various proteins in order to alert and guide neighboring cells. Majority of these proteins are not secreted through the conventional ER-Golgi secretory pathway. Instead, they are segregated in membrane-enclosed compartment and secreted in nanosized extracellular vesicles, which protect their cargo and guide it for delivery. Growing evidence indicates that inflammasome activity correlates with enhanced secretion of extracellular vesicles and modulation of their protein cargo. This inflammasome-driven unconventional, vesicle-mediated secretion of multitude of immunoregulatory proteins may constitute a novel paradigm in inflammatory responses. In this mini review we discuss the current knowledge and highlight unsolved questions about metabolic processes, signals, and mechanisms linking inflammasome activity with regulated extracellular vesicle secretion of proteins. Further investigations on this relationship may in the future help understanding the significance of extracellular vesicle secretion in inflammatory diseases such as atherosclerosis, gouty arthritis, asthma, Alzheimer's and many others.
Introduction
Extracellular vesicles (EV) are a heterogeneous group of membrane-enclosed carriers of biomolecules, secreted by all mammalian cells. This umbrella term refers to the pool of all vesicles, ranging in size from 30 to over 1,000 nm, constituting of exosomes (derived from endosomal compartment), ectosomes (microvesicles budding from plasma membrane) and apoptotic bodies [fragments of apoptotic cells, ()]. Secretion of EV by immune cells constitutes a conserved mechanism of release of biomolecules (notably proteins, bioactive lipids and nucleic acids) both as a “waste disposal” and for targeted intercellular signaling. The latter became a major focus of immunologists' research efforts in the past decade. In innate immunity, secretion of EV by leukocytes is a tightly regulated process, dependent on the activation state of the cells (). During immune response, EV are selectively loaded with immune regulatory proteins, like cytokines, what makes them important messengers delivering targeted biological signals. The vesicular signaling now emerges as a critical component of innate immunity that orchestrates actions of multiple immune system cells in infectious and inflammatory diseases.
Inflammasomes are molecular structures of the innate immune system that are critical for both local and systemic inflammation. Among them canonical NOD-like receptor protein 3 (NLRP3) is the most studied and known to sense multiple microbial and endogenous danger signals. NLRP3 activation results in caspase-1-dependent processing and secretion of critical pro-inflammatory cytokines interleukin (IL)-1β and IL-18, as well as drives pro-inflammatory cell death (pyroptosis). More recently non-canonical, caspase-4/5-dependent inflammasome has been described. These novel caspases binding to intracellular LPS, directly regulate pyroptosis, and activate canonical NLRP3-mediated IL-1β and IL-18 processing. Caspases-4/5 are critical for development of endotoxic shock in mice ().
EV secretion has long been linked with inflammation and various experimental models were applied to characterize the roles the EV play in the development and progression of inflammatory diseases. In particular, EV isolated from patient body fluids have been studied in search for disease biomarkers and early diagnosis possibilities of such inflammatory diseases as atherosclerosis (–), Alzheimer's disease (–), and rheumatoid arthritis (). EV secreted during inflammatory response are thought to promote inflammation in endothelial cells, neutrophils, hepatocytes, macrophages, and monocytes via various mechanisms: delivery of inflammasome components and cytokines, activation of surface receptors, induction of expression of inflammatory mediators and others [reviewed recently in ()].
Contrary to extensive documentation on biological functions of EV in inflammatory diseases, mechanistic explanations of how the inflammasome activity regulates secretion of EV and modulates their cargo and biological properties in inflammatory cells are vague. Use of high-throughput proteomic approaches has contributed substantially to our knowledge in these aspects and allowed to elucidate novel signals for EV secretion in inflammatory response. Using proteomics, we and others showed that canonical NLRP3 activators (calcium oxalate and monosodium urate (MSU) crystals, ATP, β-glucans, viral RNA) as well as non-canonical, caspase-4-dependent activation, induce secretion of EV and EV-associated proteins (–). In this mini review we discuss the current knowledge and highlight unsolved questions about signals, processes and mechanisms linking NLRP3 inflammasome activity with regulated EV-mediated secretion of pro-inflammatory cytokines and other immunoregulatory proteins.
Multiple canonical NLRP3 activators induce EV secretion
ATP
Extracellular ATP is an endogenous danger signal known to activate inflammatory response in innate immune cells including macrophages. The receptor for ATP is P2X purinoceptor 7 (P2X7), which is a transmembrane ATP-gated ion channel (). Ligation of P2X7 results in strong activation of NLRP3 inflammasome (). We have shown that ATP-induced NLRP3 inflammasome activation is followed by robust activation of EV-mediated protein secretion, including exosome release and membrane shedding in human macrophages (). Interestingly, de Torre-Minguela et al. showed that P2X7-induced protein secretion does not depend on de novo protein synthesis (). This observation suggests that activation of P2X7 ion channel causes rapid, probably non-specific sequestration of proteins at the vicinity of the plasma membrane and their release in shedding microvesicles. It is currently not clear if this process is inflammasome-dependent, as secretion of only part of the proteins was shown to be affected by caspase-1. Moreover, the study revealed multiple proteins whose secretion was caspase-1-dependent in M1 pro-inflammatory macrophages, but not M2, suggesting existence of more sophisticated, cell-specific regulatory mechanisms ().
Monosodium urate and β-glucans
Monosodium urate (MSU) and β-glucans are crystalline agents that activate NLRP3 inflammasome. MSU crystals have emerged as a causative factor for gouty arthritis through NLRP3 activation and following IL-1β secretion (). β-glucans are the main components of fungal cell walls and they activate robust innate immune reaction. We have shown that both MSU crystals and β-glucans activate strong EV-mediated protein secretion in human macrophages (, , ). This protein secretion was dependent on the activity of Syk kinase and lysosomal proteases cathepsins, as well as caspase-1. This indicates that Syk kinase activity and lysosome damage, which both are involved in NLRP3 inflammasome activation (), provide also a signal for the induction of EV secretion upon recognition of crystalline substances damaging lysosomes. These results also suggested that NLRP3 activity is required for MSU- and β-glucan-induced EV-mediated protein secretion.
Nigericin
Nigericin is a microbial toxin derived from Streptomyces hygroscopicus, which has the ability to induce P2X7-independent potassium efflux and following activation of the NLRP3 inflammasome. Zhang and colleagues studied the effect of LPS and nigericin on EV secretion in mouse bone marrow-derived macrophages. LPS alone was not sufficient to induce substantial EV protein secretion as compared with LPS priming followed by nigericin stimulation (). Thus, EV secretion may constitute a secondary effect of NLRP3 activity. Of note, proteomic analysis identified IL-1β and NLRP3 in the EV from LPS/nigericin-treated cells (), adding EV-mediated secretory route to previous observations of secretion of inflammasome components during inflammatory response (). Functionally, these EV were able to induce NF-κB signaling in recipient cells, suggesting that EV-mediated transport of proteins (and possibly other biomolecules) serves as a major intercellular signaling event in coordination of immune response ().
Non-canonical caspase-4/5 inflammasome activates EV secretion
The discovery that human caspases-4/5 (caspase-11 in mice) are novel pattern recognition receptors which directly recognize intracellular LPS fundamentally changed the understanding of inflammasome responses (, –). It was shown that caspases-4/5 activate NLRP3 inflammasome and processing of IL-1β and IL-18. Non-canonical caspases-4/5 also mediate cleavage of gasdermin D, yielding an N-terminal polypeptide which inserts into the cellular membrane and oligomerizes, forming a pore and inducing subsequent pyroptosis independently of NLRP3 (, ). Very recent data shows that gasdermin D also has a pyroptosis-independent function in phagocytic cells: it mediates IL-1β secretion in living macrophages which undergo “hyperactivation” in response to bacteria and oxidized lipids (). It was speculated that pyroptosis-independent IL-1β release may be a result of weak or modest activation of NLRP3 inflammasome, contrary to strong activation which triggers pyroptotic death ().
Currently very limited data concerning EV secretion associated with non-canonical inflammasome response is available. In our recent study, we utilized label-free quantitative proteomics to characterize global protein secretion in response to non-canonical caspase-4/5 inflammasome activation in human macrophages (). We demonstrated that non-canonical caspase-4/5 inflammasome activates robust EV-mediated protein secretion in human macrophages. Caspase-4 inhibitor blocked both IL-18 and EV secretion in macrophages in response to intracellular LPS treatment (). However, it was not studied if NLRP3 inflammasome (which is also activated downstream of non-canonical caspases) is involved in the activation of EV-mediated protein secretion following intracellular LPS delivery. The role of gasdermin D in generation and secretion of EV is likewise unknown.
The role of EV in NLRP3-mediated IL-1β release
Neither the 31kDa precursor nor mature 17 kDa form of IL-1β carry an N-terminal signal sequence. Upon processing by the inflammasome, mature IL-1β is targeted for release via poorly understood secretory route. Numerous mechanisms have been proposed to mediate IL-1β release, including homeostatic processes, like secretory autophagy (–) and lysosome exocytosis (), as well as radical processes, resulting in cell death: pyroptosis () and necrosis (). It has been suggested that rather than being secreted by one tightly controlled mechanism, the cytokine is exported in multiple ways simultaneously (). Recent discoveries demonstrated that IL-1β secretion proceeds through gasdermin D membrane pores (, , , ), however it is still unclear how mature cytokine is exported through the pore. It seems that gasdermin D pore-mediated release is a primary secretory route for mature IL-1β secretion at initial stages of inflammatory response, as Gsdmd−/− mouse macrophages secrete drastically reduced amounts of the cytokine upon canonical and non-canonical inflammasome stimulations (). However, as gasdermin D-deficient mutants are resistant to pyroptosis but not apoptosis, it seems plausible that additional death-related mechanisms are involved in IL-1β secretion. For example, one study argued that secretion of mature IL-1β is a result of necrotic cell death, as THP1 macrophages that survived nigericin treatment retained the cytokine, contrary to dying cells (). For more detailed perspectives on IL-1β processing and secretion the reader is referred to recent detailed reviews (, 46).
Secretion of EV constitutes also an important auxiliary mean of IL-1β export. Both pro-form and mature IL-1β and IL-18 have been also observed in shedding microvesicles released from cells upon NLRP3 activation through distinct pathways (, –). It has been suggested that sequestration of activated inflammasome complex together with IL-1β and IL-18 precursors and their secretion on EV may precede the inflammasome activation within the lumen of the vesicle, thereby proposing an attractive explanation for observing both immature and mature cytokine forms present in EV (50). However, despite these and a small number of other studies identifying the presence of IL-1β in association with vesicles, the EV have not been fully elucidated as a secretory mechanism of IL-1β and IL-18.
Mechanistic links between NLRP3 activity and EV secretion
Transmembrane calcium/potassium fluxes
Changing transmembrane ionic balance of calcium and potassium is a critical signal for canonical NLRP3 activation (51–53). Potassium efflux and concomitant calcium influx is triggered by ionophores [streptolysin O (), nigericin (55), maitotoxin ()], as well as activators of P2X7 receptor (56), which are known for their rapid inflammasome activation. NLRP3 inflammasome is also activated by intracellular release of calcium from lysosomal compartment (55, 57).
Calcium influx is also a promoter of EV secretion (58). Calcium influx activates calcium-dependent floppase and scramblase, which are involved in exposing phosphatidylserine and phosphatidyethanolamine on the outer plasma membrane sheet, causing outward budding of the membrane. Subsequent reorganization of the cytoskeleton facilitates pinching off of the forming microvesicle (59).
Calcium (Ca2+) ions are important for cellular signaling, as once they enter the cytosol of the cytoplasm they regulate the activity of many enzymes and proteins. Calpains are cytosolic calcium-sensitive enzymes, involved in processing of many cytoskeletal proteins. They are also important for secretion of EV (60, 61). Crespin et al., showed that inhibition of calpains reduces microvesicle shedding resulting from calcium ionophore treatment in platelets (62). In our study we further explored the ATP-mediated inflammasome activation and EV secretion, showing that activation of calpains may be the missing link between P2X7-mediated ionic fluxes and inflammasome activation. In human macrophages, calpain inhibition supresses inflammasome activation and IL-1β secretion upon ATP and β-glucan treatment, but surprisingly not nigericin, a P2X7-independent potassium ionophore. It also completely abrogates ATP-induced EV secretion (). This suggests that in macrophage P2X7-NLRP3 axis, calpain activation by calcium influx is required for both inflammasome activity and EV secretion, while for P2X7-independent ionophores calpain function may be dispensable.
Lysosomal damage
Lysosome destabilization occurring during phagocytosis and endocytosis of crystalline particles is another well-established trigger of NLRP3 activation. These stimuli include cholesterol crystals (63, 64), MSU (), calcium phosphate (65), and particulate β-glucans (66). During lysosomal membrane destabilization two major events have been demonstrated to play major role in triggering inflammasome assembly: leakage of lysosomal cathepsins, and potassium efflux.
Interestingly, we have also demonstrated that cathepsins play role in secretion of EV-associated proteins in the course of TLR3-mediated double-stranded RNA recognition in human macrophages in a model of viral infection (67). However whether EV secretion is modulated by cathepsin inhibition was not directly addressed. More recently, another group evaluated the roles of cathepsins in inflammasome activation, showing that neither widely used cathepsin inhibitor Ca-074-Me, nor alternative K777, are specific antagonists of a single cathepsin (68). Therefore the link between lysosome damage-induced NLRP3 activation and EV secretion is rather a combined effect of different cathepsins activity, whose roles need further elucidation. This also remains to be confirmed e.g., by using selective NLRP3 inhibitors. Concomitantly, the involvement of Syk and lysosomal cathepsins in activation of EV secretion needs also to be verified for other particulate NLRP3 activators like alum, asbestos or silica.
Caspase-1 activity
Caspase-1, beyond its well-documented pro-IL-1β and pro-IL-18-processing functions, is also involved in secretion of other leaderless proteins. Keller and colleagues demonstrated that UVB irradiation-activated keratinocytes secrete over 900 proteins, of which secretion of 77 was significantly modulated in the presence of caspase-1 inhibitor YVAD (69). Interestingly, only a small number of these proteins are known to be direct caspase-1 targets (70). Many of them are also known to be secreted via EV. This revealed that caspase-1 may be directly involved in control of EV secretion and loading (70).
Moreover, upon discovering that inflammasome complexes can be secreted in EV, it has been proposed that caspase-1 activation is critical for sequestration of ASC specks and other inflammasome components in vesicular compartment for secretion and delivery to neighboring cells. Uptake of such “inflammasome-EV” is perceived as a mean of local propagation of inflammatory response (71, 72).
In contrast, a study published by Qu et al. argued against the critical role of caspase-1 in P2X7-mediated activation of EV secretion. The authors suggested that exosome secretion is a consequence of NLRP3 and ASC activity, while caspase-1 was dispensable (73). However, this study was performed on murine bone marrow-derived macrophages and dendritic cells and the EV secretion was mainly assessed by immunoblotting of MHCII, which is not a classical exosomal/EV marker, with lack of other validation methods. Corroborating this data, our study also indicated that caspase-1 inhibition by Z-YVAD-FMK was insufficient to prevent EV-mediated protein secretion induced by ATP in human macrophages ().
Conclusions and perspectives
Secretion of EV is currently perceived as a fundamental mode of intercellular communication, having impact on cell-to-cell delivery of proteins, lipids and nucleic acids. Circulating EV form a signaling network of the immune system, where various cells in blood and tissues exchange EV which coordinate homeostasis and alert the immune system upon sensing the danger. Growing number of studies now support the view that human phagocytic cells modulate secretion kinetics and cargo of EV during inflammatory response. There is strong evidence that EV secretion correlates with inflammasome activity (, –, , ) and that the “inflammasome-induced” EV can activate inflammatory responses in recipient cells (). Therefore activation of EV secretion via different mechanisms is possibly a universal outcome of inflammasome activity with evolutionary determined immune signaling.
Based on the available data, we postulate a model of inflammasome-dependent EV secretion as a sequential process, which serves the release of pro-inflammatory cytokines, as well as numerous other proteins whose relationship to inflammasome remains to be determined (Figure 1). Signal 1, delivered by surface PRRs during priming induces expression of inflammasome components and pro-inflammatory cytokines, but activates no inflammasome assembly or significant EV secretion [(), Figure 1A]. Upon signal 2, assembly of the inflammasome with caspase-1 activation triggers processing of pro-inflammatory cytokines and gasdermin D. Active gasdermin D translocates to the membrane forming pores for cytokine secretion, but also further affecting transmembrane calcium/potassium equilibrium (Figure 1B). Cationic fluxes amplify signal 2 and simultaneously affect two parallel processes that facilitate formation and secretion of EV: (a) activating inflammatory caspases (possibly including non-canonical caspases 4 and 5) that are directly or indirectly involved in processing cytoskeletal proteins, compromising membrane rigidity and microvesicle formation, (b) modulating reorganization of plasma membrane sheets, with phosphatidylserine exposure as a result of calcium-activated phospholipid transporters. The forming shedding compartment carries the local cargo proteins, including processed and unprocessed cytokines, or even entire inflammasome complexes. Mature cytokines may also be targeted to multivesicular bodies (MVB) and secreted in exosomes. Thus at this stage, formation of EV via multiple mechanisms may postpone imminent cell death by removal of active inflammasome, and enhance the secretion of IL-1β (Figure 1C). During prolonged exposure to signal 2, the cell undergoes pyroptotic cell death, which is associated with membrane damage and leakage of cytoplasm contents. However, several studies suggested existence of caspase-1-dependent cell death that resembles apoptosis that may be activated concomitantly to pyroptosis or at later stages (74–77). Indeed Gsdmd deletion causes a shift from pyroptotic to apoptotic-like phenotype in mouse models (). Similarly to classical apoptosis, such process may be associated with compartmentalization of cellular content and effective formation of EV similar to apopotic bodies (Figure 1D). Current knowledge about these “pyroptotic vesicles” is very limited, however their release has been showed in our recent study (). Consequently, EV-mediated secretion may be a major inflammasome-dependent secretory route of IL-1β, IL-18, and other proteins important for coordination of immune response. There are however several questions still seeking answers. First—do all NLRP3 inflammasome activators enhance secretion of EV? Currently only a handful of canonical and one non-canonical NLRP3 stimulus have been directly shown to induce EV secretion. It has also not been determined whether EV secretion occurs via one preferred route, dependent possibly on a particular signal, or alternatively involving exosomes, shedding microvesicles and blebs to a similar extent. Second—it is obvious that kinetics of EV release varies significantly and may range from minutes (ATP) to hours (β-glucan) after inflammasome activation (, ). In order to corroborate the view of inflammasome-activated EV secretion, it is important to further investigate the patterns and kinetics of “weak” and “strong” NLRP3 activators () in stimulating EV secretion. Finally, it will be essential to dissect the signal transduction pathways activated by different inflammasome stimuli on one hand, and those downstream NLRP3 and caspases-4/5 on the other, monitoring their roles in formulation, cargo selection and secretion of EV. These investigations may in the future provide novel explanations on inflammasome and EV biology improving understanding of inflammatory diseases and revealing novel therapeutic targets.
Figure 1
Statements
Author contributions
WC and SM designed and wrote the manuscript. TN critically revised the manuscript.
Funding
This work was funded by the statutory funds of the Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
Yáñez-MóMSiljanderPRAndreuZZavecABBorràsFEBuzasEIet al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 4:27066. 10.3402/jev.v4.27066
2.
NymanTALoreyMBCyprykWMatikainenS. Mass spectrometry-based proteomic exploration of the human immune system: focus on the inflammasome, global protein secretion, and T cells. Expert Rev Proteomics (2017) 14:395–407. 10.1080/14789450.2017.1319768
3.
ShiJZhaoYWangYGaoWDingJLiPet al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature (2014) 514(7521):187–92. 10.1038/nature13683
4.
HulsmansMHolvoetP. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res. (2013) 100:7–18. 10.1093/cvr/cvt161
5.
PerrottaIAquilaS. The role of oxidative stress and autophagy in atherosclerosis. Oxid Med Cell Longev. (2015) 2015:130315. 10.1155/2015/130315
6.
HafianeADaskalopoulouSS. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease. Metabolism (2018) 85:213–22. 10.1016/j.metabol.2018.04.008
7.
GhidoniRPaterliniAAlbertiniVGlionnaMMontiESchiaffonatiLet al. Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiol Aging (2011) 32:1435–42. 10.1016/j.neurobiolaging.2009.08.013
8.
GuiYLiuHZhangLLvWHuX. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget (2015) 6:37043–53. 10.18632/oncotarget.6158
9.
YangTTLiuCGGaoSCZhangYWangPC. The serum exosome derived microRNA-135a,−193b, and−384 were potential alzheimer's disease biomarkers. Biomed Environ Sci. (2018) 31:87–96. 10.3967/bes2018.011
10.
GoetzlEJSchwartzJBAbnerELJichaGAKapogiannisD. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. (2018) 83:544–52. 10.1002/ana.25172
11.
WithrowJMurphyCLiuYHunterMFulzeleSHamrickMW. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. (2016) 18:286. 10.1186/s13075-016-1178-8
12.
vanHezel MENieuwlandRBruggenRVJuffermansNP. The ability of extracellular vesicles to induce a pro-inflammatory host response. Int J Mol Sci. (2017) 18:E1285. 10.3390/ijms18061285
13.
VälimäkiEMiettinenJJLietzénNMatikainenSNymanTA. Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages. Mol Cell Proteomics (2013) 12:749–63. 10.1074/mcp.M112.024661
14.
CyprykWOhmanTEskelinenELMatikainenSNymanTA. Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon β-glucan stimulation. J Proteome Res. (2014) 13:2468–77. 10.1021/pr4012552
15.
VälimäkiECyprykWVirkanenJNurmiKTurunenPMEklundKKet al. Calpain activity is essential for ATP-driven unconventional vesicle-mediated protein secretion and inflammasome activation in human macrophages. J Immunol. (2016) 197:3315–25. 10.4049/jimmunol.1501840
16.
CyprykWLoreyMPuustinenANymanTAMatikainenS. Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection. J Proteome Res. (2017) 16:217–27. 10.1021/acs.jproteome.6b00596
17.
LoreyMBRossiKEklundKKNymanTAMatikainenS. Global characterization of protein secretion from human macrophages following non-canonical caspase-4/5 inflammasome activation. Mol Cell Proteomics (2017) 16(4 suppl. 1):S187–99. 10.1074/mcp.M116.064840
18.
SinghtoNKanlayaRNilnumkhumAThongboonkerdV. Roles of macrophage exosomes in immune response to calcium oxalate monohydrate crystals. Front Immunol. (2018) 9:316. 10.3389/fimmu.2018.00316
19.
SurprenantARassendrenFKawashimaENorthRABuellG. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 272:735–8.
20.
MariathasanSWeissDSNewtonKMcBrideJO'RourkeKRoose-GirmaMet al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 440:228–32. 10.1038/nature04515
21.
deTorre-Minguela CBarberà-CremadesMGómezAIMartín-SánchezFPelegrínP. Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep. (2016) 6:22586. 10.1038/srep22586
22.
MartinonFPétrilliVMayorATardivelATschoppJ. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 440:237–41. 10.1038/nature0451
23.
ÖhmanTTeiriläLLahesmaa-KorpinenAMCyprykWVeckmanVSaijoSet al. Dectin-1 pathway activates robust autophagy-dependent unconventional protein secretion in human macrophages. J Immunol. (2014) 192:5952–62. 10.4049/jimmunol.1303213
24.
HornungVLatzE. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol. (2010) 40:620–3. 10.1002/eji.200940185
25.
ZhangYLiuFYuanYJinCChangCZhuYet al. Inflammasome-derived exosomes activate NF-κB signaling in macrophages. J Proteome Res. (2017) 16:170–178. 10.1021/acs.jproteome.6b00599
26.
KayagakiNWarmingSLamkanfiMVandeWalle LLouieSDongJet al. Non-canonical inflammasome activation targets caspase-11. Nature (2011) 479:117–21. 10.1038/nature10558
27.
BrozPRubyTBelhocineKBouleyDMKayagakiNDixitVMet al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature (2012) 490:288–91. 10.1038/nature11419
28.
MeunierEDickMSDreierRFSchürmannNKenzelmannBroz DWarmingSet al. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature (2014) 509:366–70. 10.1038/nature13157
29.
Schmid-BurgkJLGaidtMMSchmidtTEbertTSBartokEHornungV. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol. (2015) 45:2911–7. 10.1002/eji.201545523
30.
KayagakiNStoweIBLeeBLO'RourkeKAndersonKWarmingSet al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature (2015) 526:666–71. 10.1038/nature15541
31.
HeWTWanHHuLChenPWangXHuangZet al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. (2015) 25:1285–98. 10.1038/cr.2015.139
32.
ManSMKarkiRSasaiMPlaceDEKesavardhanaSTemirovJet al. IRGB10 liberates bacterial ligands for sensing by the AIM2 and caspase-11-NLRP3 inflammasomes. Cell (2016) 167:382–96.e17. 10.1016/j.cell.2016.09.012
33.
LiuXZhangZRuanJPanYMagupalliVGWuHet al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature (2016) 535:153–8. 10.1038/nature18629
34.
MulvihillESborgiLMariSAPfreundschuhMHillerSMüllerDJ. Mechanism of membrane pore formation by human gasdermin-D. EMBO J (2018) 37:e98321. 10.15252/embj.201798321
35.
EvavoldCLRuanJTanYXiaSWuHKaganJC. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity (2018) 48:35–44.e6. 10.1016/j.immuni.2017.11.013
36.
KuriakoseTKannegantiTD. Gasdermin D flashes an exit signal for IL-1. Immunity (2018) 48:1–3. 10.1016/j.immuni.2018.01.003
37.
DupontNJiangSPilliMOrnatowskiWBhattacharyaDDereticV. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. (2011) 30:4701–11. 10.1038/emboj.2011.398
38.
HarrisJHartmanMRocheCZengSGO'SheaASharpFAet al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. (2011) 286:9587–97. 10.1074/jbc.M110.202911
39.
IulaLKeitelmanIASabbioneFFuentesFGuzmanMGallettiJGet al. Autophagy mediates interleukin-1β secretion in human neutrophils. Front Immunol. (2018) 9:269. 10.3389/fimmu.2018.00269
40.
Claude-TaupinABissaBJiaJGuYDereticV. Role of autophagy in IL-1β export and release from cells. Semin Cell Dev Biol. (2018). [Epub ahead of print]. 10.1016/j.semcdb.2018.03.012
41.
QuYFranchiLNunezGDubyakGR. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol. (2007) 179:1913–25. 10.4049/jimmunol.179.3.1913
42.
CullenSPKearneyCJClancyDMMartinSJ. Diverse activators of the NLRP3 inflammasome promote IL-1β secretion by triggering necrosis. Cell Rep. (2015) 11:1535–48. 10.1016/j.celrep.2015.05.003
43.
Lopez-CastejonGBroughD. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. (2011) 22:189–95. 10.1016/j.cytogfr.2011.10.001
44.
BroughDPelegrinPNickelW. An emerging case for membrane pore formation as a common mechanism for the unconventional secretion of FGF2 and IL-1β. J Cell Sci. (2017) 130:3197–3202. 10.1242/jcs.204206
45.
ShiJZhaoYWangKShiXWangYHuangHet al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature (2015) 526:660–5. 10.1038/nature15514
46.
SitiaRRubartelliA. The unconventional secretion of IL-1β: Handling a dangerous weapon to optimize inflammatory responses. Semin Cell Dev Biol. (2018). [Epub ahead of print]. 10.1016/j.semcdb.2018.03.011
47.
PizziraniCFerrariDChiozziPAdinolfiESandonàDSavaglioEet al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood (2007) 109:3856–64. 10.1182/blood-2005-06-031377
48.
GulinelliSSalaroEVuerichMBozzatoDPizziraniCBolognesiGet al. IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independent mechanism in response to P2X receptor stimulation. Eur J Immunol. (2012) 42:3334–45. 10.1002/eji.201142268
49.
YoonSKovalenkoABogdanovKWallachD. MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation. Immunity (2017) 47:51–65.e7. 10.1016/j.immuni.2017.06.001
50.
PradaIFurlanRMatteoliMVerderioC. Classical and unconventional pathways of vesicular release in microglia. Glia (2013) 61:1003–17. 10.1002/glia.22497
51.
PerregauxDGabelCA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem. (1994) 269:15195–203.
52.
PicciniACartaSTassiSLasigliéDFossatiGRubartelliA. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA. (2008) 105:8067–72. 10.1073/pnas.0709684105
53.
Muñoz-PlanilloRKuffaPMartínez-ColónGSmithBLRajendiranTMNúñezG. K? efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity (2013) 38:1142–53. 10.1016/j.immuni.2013.05.016
54.
HarderJFranchiLMuñoz-PlanilloRParkJHReimerTNúñezG. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol. (2009) 183:5823–9. 10.4049/jimmunol.0900444
55.
MurakamiTOckingerJYuJBylesVMcCollAHoferAMet al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci USA. (2012) 109:11282–7. 10.1073/pnas.1117765109
56.
PerregauxDGLaliberteREGabelCA. Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem. (1996) 271:29830–8.
57.
HallerTDietlPDeetjenPVölklH. The lysosomal compartment as intracellular calcium store in MDCK cells: a possible involvement in InsP3-mediated Ca2+ release. Cell Calcium (1996) 19:157–65.
58.
TissotJ-DCanelliniGRubinOAngelillo-ScherrerADelobelJPrudentMet al. Blood microvesicles: from proteomics to physiology. Transl Proteomics (2013) 1:38–52. 10.1016/j.trprot.2013.04.004
59.
KalraHDrummenGPMathivananS. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci. (2016) 17:170. 10.3390/ijms17020170
60.
SaidoTCSorimachiHSuzukiK. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. (1994) 8:814–22.
61.
WeberHHühnsSLüthenFJonasL. Calpain-mediated breakdown of cytoskeletal proteins contributes to cholecystokinin-induced damage of rat pancreatic acini. Int J Exp Pathol. (2009) 90:387–99. 10.1111/j.1365-2613.2009.00638.x
62.
CrespinMVidalCPicardFLacombeCFontenayM. Activation of PAK1/2 during the shedding of platelet microvesicles. Blood Coagul Fibrinol. (2009) 20:63–70. 10.1097/MBC.0b013e32831bc310
63.
DuewellPKonoHRaynerKJSiroisCMVladimerGBauernfeindFGet al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 464:1357–61. 10.1038/nature08938
64.
RajamäkiKLappalainenJOörniKVälimäkiEMatikainenSKovanenPTet al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE (2010) 5:e11765. 10.1371/journal.pone.0011765
65.
PazárBEaHKNarayanSKollyLBagnoudNChobazVet al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro. J Immunol. (2011) 186:2495–502. 10.4049/jimmunol.1001284
66.
KankkunenPTeiriläLRintahakaJAleniusHWolffHMatikainenS. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J Immunol. (2010) 184:6335–42. 10.4049/jimmunol.0903019
67.
RintahakaJLietzénNÖhmanTNymanTAMatikainenS. Recognition of cytoplasmic RNA results in cathepsin-dependent inflammasome activation and apoptosis in human macrophages. J Immunol. (2011) 186:3085–92. 10.4049/jimmunol.1002051
68.
OrlowskiGMColbertJDSharmaSBogyoMRobertsonSARockKL. Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation. J Immunol. (2015) 195:1685–97. 10.4049/jimmunol.1500509
69.
KellerMRüeggAWernerSBeerHD. Active caspase-1 is a regulator of unconventional protein secretion. Cell (2008) 132:818–31. 10.1016/j.cell.2007.12.040
70.
ShaoWYeretssianGDoironKHussainSNSalehM. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem. (2007) 282:36321–9. 10.1074/jbc.M708182200
71.
deRivero Vaccari JPBrandF IIIAdamczakSLeeSWPerez-BarcenaJWangMYet al. Exosome-mediated inflammasome signaling after central nervous system injury. J Neurochem. (2016) 136(Suppl. 1):39–48. 10.1111/jnc.13036
72.
WangLFuHNanayakkaraGLiYShaoYJohnsonCet al. Novel extracellular and nuclear caspase-1 and inflammasomes propagate inflammation and regulate gene expression: a comprehensive database mining study. J Hematol Oncol. (2016) 9:122. 10.1186/s13045-016-0351-5
73.
QuYRamachandraLMohrSFranchiLHardingCVNunezGet al. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol. (2009) 182:5052–62. 10.4049/jimmunol.0802968
74.
PieriniRJurujCPerretMJonesCLMangeotPWeissDSet al. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ. (2012) 19:1709–21. 10.1038/cdd.2012.51
75.
SagulenkoVThygesenSJSesterDPIdrisACridlandJAVajjhalaPRet al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. (2013) 20:1149–60. 10.1038/cdd.2013.37
76.
AachouiYSagulenkoVMiaoEAStaceyKJ. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr Opin Microbiol. (2013) 16:319–26. 10.1016/j.mib.2013.04.004
77.
LeeBLMirrashidiKMStoweIBKummerfeldSKWatanabeCHaleyBet al. ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages. Sci Rep. (2018) 8:3788. 10.1038/s41598-018-21998-3
Summary
Keywords
inflammasome, inflammation, extracellular vesicle (EV), signaling, EV
Citation
Cypryk W, Nyman TA and Matikainen S (2018) From Inflammasome to Exosome—Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?. Front. Immunol. 9:2188. doi: 10.3389/fimmu.2018.02188
Received
20 June 2018
Accepted
04 September 2018
Published
25 September 2018
Volume
9 - 2018
Edited by
Rongbin Zhou, University of Science and Technology of China, China
Reviewed by
Robson Coutinho-Silva, Universidade Federal do Rio de Janeiro, Brazil; Sinisa Savic, University of Leeds, United Kingdom
Updates
Copyright
© 2018 Cypryk, Nyman and Matikainen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wojciech Cypryk wcypryk@cbmm.lodz.pl
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.